Invention Application
- Patent Title: AZA-BICYCLOALKYL ETHERS AND THEIR USE AS ALPHA7-NACHR AGONISTS
-
Application No.: US15398427Application Date: 2017-01-04
-
Publication No.: US20170112814A1Publication Date: 2017-04-27
- Inventor: Dominik Feuerbach , Konstanze Hurth , Timothy John Ritchie , Rochdi Bouhelal
- Applicant: Novartis AG
- Main IPC: A61K31/439
- IPC: A61K31/439 ; A61K9/20
Abstract:
The present invention relates to 1-aza-bicycloalkyl derivatives of formula I, wherein X is CH2 or a single bond; Y is a group of formula and wherein R has the meanings as defined in the specification, which compounds are alpha 7 nicotinic acetylcholine receptor (nAChR) agonists; to processes for their production, their use as pharmaceuticals and to pharmaceutical compositions comprising them.
Public/Granted literature
- US09849117B2 Aza-bicycloalkyl ethers and their use as alpha7-nachr agonists Public/Granted day:2017-12-26
Information query
IPC分类:
